Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than changes to study details. This change reflects a backend or content polish and does not affect the recorded trial information presented on the page.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:20.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, signaling a newer version of the page. This appears to be a small update to the page's text or formatting rather than a change to study data.
    Difference
    0.0%
    Check dated 2026-06-27T00:09:06.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate the study is closed to new participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. The Intervention/Treatment heading formatting was standardized (adding 'Intervention/Treatment' and removing the variant 'Intervention / Treatment'), and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:48:36.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a small backend update to the page's version history.
    Difference
    0.0%
    Check dated 2026-06-05T13:17:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows a Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor system update rather than any change to the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:29.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, representing a small platform update to the page. This change does not modify study content, eligibility, or results.
    Difference
    0.0%
    Check dated 2026-04-30T18:36:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.